Is Psilocybin Safe? Side Effects, Risks and Who Should Avoid It

The physical safety profile

In supervised trials, psilocybin's physical effects are mild and short-lived: temporary increases in heart rate and blood pressure, nausea, headache and fatigue. Serious medical events are rare in screened participants, which is why the FDA's psychedelic research guidance focuses heavily on psychological support rather than medical rescue.

Common short-term side effects

• Nausea, especially in the first hour
• Anxiety or fear during the peak of the experience
• Headache, typically the following day
• Temporary confusion or emotional intensity

The real risks are psychological

The most significant danger is a destabilizing psychological reaction. A small number of people — particularly those with a personal or family history of psychosis, schizophrenia or bipolar mania — can experience lasting worsening of symptoms. This is why every reputable trial screens these conditions out.

There is also the setting problem. Clinical results come from calm rooms with two trained facilitators. Unsupervised use — unknown doses, no screening, no support — carries risks that trial data simply does not cover, including accidents during intoxication and distressing experiences with no one to help.

Who should avoid psilocybin

• Anyone with a personal or family history of psychotic disorders
• People with bipolar I disorder or a history of mania
• Those with uncontrolled high blood pressure or serious heart conditions
• Anyone on medications that interact with serotonin without medical guidance
• Pregnant or breastfeeding people

What about addiction?

Psilocybin is not considered addictive. It does not produce compulsive use, tolerance builds almost immediately, and researchers are in fact studying it as a treatment for substance use disorders.

The bottom line

In screened adults, with professional support, psilocybin has one of the better safety profiles in psychiatry. Outside that framework, the risks rise — which is why researchers consistently warn against self-treatment.